Exploring synergistic effects: Atorvastatin and electrical stimulation in spinal cord injury therapy

Exploring synergistic effects: Atorvastatin and electrical stimulation in spinal cord injury therapy

Spinal cord trauma represents a significant clinical challenge, and improving patient outcomes is a main priority for many scientific teams globally. Despite advances in the understanding its pathogenesis, the overall mechanisms occurring in the spinal cord after traumatic injury remain unclear. Thi...

Full description

Saved in:

Bibliographic Details
Main Authors:	Martina Magurova, Maria Bacova, Stefania Papcunova, Katarina Kiss Bimbova, Tomas Kuruc, Alexandra Kisucka, Lenka Ihnatova, Karolina Kucharova, Nadezda Lukacova, Jan Galik
Format:	Article
Language:	English
Published:	Elsevier 2025-06-01
Series:	IBRO Neuroscience Reports
Subjects:	Spinal cord injury Oscillating field stimulation Atorvastatin Behavioral assessment Functional recovery Axonal regeneration
Online Access:	http://www.sciencedirect.com/science/article/pii/S2667242125000302
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Mitochondrial dynamics reveal potential to facilitate axonal regeneration after spinal cord injury
by: Kaixuan Wang, et al.
Published: (2025-06-01)

Nanomaterials for promoting axon regeneration after spinal cord injury: Mechanisms and prospects
by: Jia Liu, et al.
Published: (2025-07-01)

Analysis of the binary mixtures of amlodipine and atorvastatin by chemometric-spectophotometric method
by: Hayrettin Bulum, et al.
Published: (2025-06-01)

Lipid-lowering effectiveness of a Russian generic of atorvastatin in patients with various hyperlipidaemia phenotypes
by: P. P. Malyshev, et al.
Published: (2009-12-01)

EFFICACY AND SAFETY OF THERAPY WITH ATORVASTATIN IN HIGH DOSES
by: A. N. Meshkov
Published: (2016-01-01)

Marcks and Marcks-like 1 proteins promote spinal cord development and regeneration in Xenopus
by: Mohamed El Amri, et al.
Published: (2024-12-01)

EFFICIENCY AND SAFETY ASSESSMENT OF GENERIC ATORVASTATINE IN PATIENTS WITH HYPERLIPIDEMIA
by: J. E. Semyonova, et al.
Published: (2015-12-01)

Intravenous infusion of mesenchymal stem cells increased axonal signal intensity in the rubrospinal tract in spinal cord injury
by: Ryosuke Hirota, et al.
Published: (2025-04-01)

ATORVASTATIN — 20 YEARS IN THE STRUGGLE FOR LIFE
by: N. G. Gogolashvili
Published: (2018-03-01)

Inosine Improves Functional Recovery and Cell Morphology Following Compressive Spinal Cord Injury in Mice
by: Ricardo Cardoso, et al.
Published: (2024-11-01)

EFFECTS OF ATORVASTATIN IN PATIENTS WITH RHEUMATOID ARTHRITIS AND DYSLIPIDEMIA
by: N. M. Nikitina, et al.
Published: (2014-07-01)

The impact of atorvastatin on hemorheology and inflammatory cytokines of patients with hypertensive nephropathy
by: WANG Li, et al.
Published: (2017-01-01)

Histological Alterations Induced by Atorvastatin Therapeutic Doses in some Organs of Male Albino Rats
by: Twana Ahmed Mustafa, et al.
Published: (2019-04-01)

Atorvastatin effectiveness in dyslipidemia correction among coronary heart disease and arterial hypertension patients with high risk of cardiovascular complications
by: E. V. Minakov, et al.
Published: (2007-10-01)

ATORVASTATIN IN ACUTE AND CHRONIC KINDS OF ISCHEMIC HEART DISEASE
by: V. E. Oleynikov, et al.
Published: (2015-11-01)

STATINS AND PERCUTANEOUS CORONARY INTERVENTION. FOCUS ON THE ATORVASTATIN
by: N. G. Gogolashvili
Published: (2015-09-01)

Atorvastatin: evidence base 15 years later
by: A. V. Susekov, et al.
Published: (2011-06-01)

Fabrication and evaluation of solidified nanoemulsion designs for systemic delivery of atorvastatin through the lung
by: Muhammad Danish Saeed, et al.
Published: (2025-07-01)

Dose-dependent effects of atorvastatin in the hospitalisation period of myocardial infarction
by: O. L. Barbarash, et al.
Published: (2013-06-01)

Atorvastatin blocks Sonic Hedgehog medulloblastoma progression through apoptosis
by: R.E. Gordon, et al.
Published: (2017-12-01)

A case of rhabdomyolysis after atorvastatin therapy of a liver transplant recipient receiving immunosuppressive therapy with cyclosporine
by: A. V. Shabunin, et al.
Published: (2021-06-01)

Correlation of atorvastatin with subjective memory deficits: a study from the NHANES and FAERS databases
by: Hao Zhang, et al.
Published: (2025-03-01)

Statinotherapy – the paradigm of prevention and treatment of atherosclerotic pathology (focus on atorvastatin)
by: R. G. Oganov, et al.
Published: (2006-12-01)

USE OF DISSOLUTION TEST FOR EVALUATION OF PHARMACEUTICAL EQUIVALENCE OF ATORVASTATIN GENERICS
by: O. V. Druzhininskaya, et al.
Published: (2019-01-01)

Activated alpha 9 integrin expression enables sensory pathway reconstruction after spinal cord injury
by: Katerina Stepankova, et al.
Published: (2025-05-01)

Aggressive statin therapy in acute coronary syndrome: therapeutic potential of atorvastatin in the daily dose of 80 mg
by: A. N. Britov
Published: (2009-12-01)

Inhibitory effects of Caveolin-1-m ediated atorvastatin on vasoconstriction of interlobar renal artery in SHR rats
by: XIE Xiao-ping, et al.
Published: (2017-01-01)

Slit-Robo signaling supports motor neuron avoidance of the spinal cord midline through DCC antagonism and other mechanisms
by: Kelsey R. Nickerson, et al.
Published: (2025-04-01)

Systemic evaluation of inclisiran on the risk of new-onset diabetes and hyperglycemia compared to evolocumab and atorvastatin
by: Fei Li, et al.
Published: (2025-07-01)

ANTIATHEROGENIC AND PLEIOTROPIC ACTIVITY OF VARIOUS DOSES OF ATORVASTATIN IN PATIENTS WITH ISCHEMIC STROKE
by: M. G. Bubnova, et al.
Published: (2013-08-01)

Dyslipidemia correction with atorvastatin in patients with coronary heart disease and arterial hypertension
by: N. B. Amirov, et al.
Published: (1970-01-01)

Effect of atorvastatin gel in non-surgical treatment of peri-implant mucositis: A randomized controlled clinical trial
by: Azin Khorramdel, et al.
Published: (2024-11-01)

Efficacy and Safety of the Fixed-Dose Combination of Atorvastatin/Fenofibrate Versus Atorvastatin on the Lipid Profile of Patients with Type 2 Diabetes and Dyslipidemia
by: Francisco G. Padilla-Padilla, et al.
Published: (2025-05-01)

Novel Tissue Engineering Scaffolds in the Treatment of Spinal Cord Injury—A Bibliometric Study
by: Yan Zhao, et al.
Published: (2025-03-01)

Delayed atorvastatin delivery promotes recovery after experimental spinal cord injury
by: Samuel C. Buchl, et al.
Published: (2025-03-01)

Electrochemical sensing platform based on Ag-Fe metal–organic framework for electrocatalytic determination of Atorvastatin
by: Fatemeh Naji Siyahmazgi, et al.
Published: (2025-01-01)

Influence of atorvastatin therapy on biological markers and cardiovascular risk in patients with chronic lymphocytic leukemia in remission
by: B.B. Samura
Published: (2019-02-01)

Atorvastatin Calcium Enhances Ferroptosis in Breast Cancer Cells Through Mechanisms Involving DECR1
by: Yao Li, et al.
Published: (2025-06-01)

Long-term low-dose atorvastatin therapy and prevention of macroangiopathy complications in elderly patients with Type 2 diabetes mellitus
by: G. A. Batrak, et al.
Published: (2010-06-01)

Unveiling the Temporal Dynamics and Molecular Regulation Profiles of Neutrophil Extracellular Traps Following Spinal Cord Injury
by: Li J, et al.
Published: (2025-08-01)